These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data Sets. Fiala MA; Dukeman J; Tuchman SA; Keller M; Vij R; Wildes TM JCO Clin Cancer Inform; 2017; 1():. PubMed ID: 30547156 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology, Staging, and Management of Multiple Myeloma. Padala SA; Barsouk A; Barsouk A; Rawla P; Vakiti A; Kolhe R; Kota V; Ajebo GH Med Sci (Basel); 2021 Jan; 9(1):. PubMed ID: 33498356 [TBL] [Abstract][Full Text] [Related]
6. A Rare Coexistence of Multiple Myeloma and Polycythemia Vera. Landsman A; Barua P; Podrumar A J Hematol; 2023 Oct; 12(5):227-230. PubMed ID: 37936979 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and therapy of multiple myeloma: current aspects]. Betticher DC; Cerny T; Fey MF Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848 [TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma: diagnosis and treatment. Nau KC; Lewis WD Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734 [TBL] [Abstract][Full Text] [Related]
11. Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study. Xu J; Wang M; Shen Y; Yan M; Xie W; Wang B; Liu H; Cen X Cancer Manag Res; 2021; 13():1343-1356. PubMed ID: 33603480 [TBL] [Abstract][Full Text] [Related]
12. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy]. Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822 [No Abstract] [Full Text] [Related]
14. Bone Tumors: Multiple Myeloma. Kane SF FP Essent; 2020 Jun; 493():30-35. PubMed ID: 32573185 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management. Hillengass J; Moehler T; Hundemer M Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683 [TBL] [Abstract][Full Text] [Related]
16. Management and prognosis of multiple myeloma. Kyle RA; Elveback LR Mayo Clin Proc; 1976 Dec; 51(12):751-60. PubMed ID: 792581 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management. Maciocia N; Wechalekar A; Yong K Hematol Oncol; 2017 Dec; 35(4):432-439. PubMed ID: 27804161 [TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ]. Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009 [TBL] [Abstract][Full Text] [Related]
19. Factors affecting outcome of patients with multiple myeloma. Basit A; Siddiqui N; Hameed A; Muzaffar N; Athar S J Ayub Med Coll Abbottabad; 2014; 26(3):376-9. PubMed ID: 25671952 [TBL] [Abstract][Full Text] [Related]
20. SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of 'biomarker-defined early multiple myeloma'-a systematic review with meta-analysis. Ludwig H; Kainz S; Schreder M; Zojer N; Hinke A EClinicalMedicine; 2023 Apr; 58():101910. PubMed ID: 36969337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]